Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs (Q27628948)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs	scientific article

Statements

scholarly article

0 references

Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs (English)

0 references

Alzheimer's disease

1 reference

based on heuristic

inferred from title

Pacific electric ray

object named as

Torpedo californica

1 reference

based on heuristic

inferred from title

5

object named as

D Lamba

0 references

4

object named as

G Fels

0 references

author name string

C Bartolucci

1

0 references

E Perola

2

0 references

C Pilger

3

0 references

language of work or name

0 references

publication date

1 February 2001

0 references

0 references

42

0 references

2

0 references

182-91

0 references

Alzheimer's disease: the amyloid cascade hypothesis

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Biochemistry of altered brain proteins in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

The rationale for E2020 as a potent acetylcholinesterase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

The pharmacology of galanthamine and its analogues

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

"Back door" opening implied by the crystal structure of a carbamoylated acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Processing of X-ray diffraction data collected in oscillation mode

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

The Protein Data Bank

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Improved methods for building protein models in electron density maps and the location of errors in these models

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Automated docking of substrates to proteins by simulated annealing

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Pharmacokinetics of galanthamine hydrobromide (Nivalin) following single intravenous and oral administration in rats

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

A modular treatment of molecular traffic through the active site of cholinesterase

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Anticholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type dementia.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Crystal structure of mouse acetylcholinesterase. A peripheral site-occluding loop in a tetrameric assembly

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Accurate bond and angle parameters for X-ray protein structure refinement

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

The X-ray Structure of a Transition State Analog Complex Reveals the Molecular Origins of the Catalytic Power and Substrate Specificity of Acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Active-site gorge and buried water molecules in crystal structures of acetylcholinesterase from Torpedo californica 1 1Edited by R. Huber

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Purification and crystallization of a dimeric form of acetylcholinesterase from Torpedo californica subsequent to solubilization with phosphatidylinositol-specific phospholipase C

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Aromatic rings act as hydrogen bond acceptors

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Acetylthiocholine binds to asp74 at the peripheral site of human acetylcholinesterase as the first step in the catalytic pathway

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Potent acetylcholinesterase inhibitors: design, synthesis, and structure-activity relationships of bis-interacting ligands in the galanthamine series

1 reference

https://api.crossref.org/works/10.1002%2F1097-0134%2820010201%2942%3A2%3C182%3A%3AAID-PROT50%3E3.0.CO%3B2-1

21 January 2018

Identifiers

10.1002/1097-0134(20010201)42:2<182::AID-PROT50>3.0.CO;2-1

0 references

release_uusojqoynzduhn7fstykrtsqfq

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27628948&oldid=2042055323"